1.45
|
9.39e-64
|
GO:0044260
|
cellular macromolecule metabolic process
|
1.52
|
4.71e-60
|
GO:0031323
|
regulation of cellular metabolic process
|
1.40
|
3.02e-59
|
GO:0043170
|
macromolecule metabolic process
|
1.51
|
2.30e-57
|
GO:0080090
|
regulation of primary metabolic process
|
1.61
|
1.29e-55
|
GO:0010556
|
regulation of macromolecule biosynthetic process
|
1.59
|
1.34e-55
|
GO:0051171
|
regulation of nitrogen compound metabolic process
|
1.46
|
2.03e-55
|
GO:0019222
|
regulation of metabolic process
|
1.51
|
2.13e-55
|
GO:0060255
|
regulation of macromolecule metabolic process
|
1.59
|
1.03e-54
|
GO:0019219
|
regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.59
|
1.90e-54
|
GO:0010468
|
regulation of gene expression
|
1.58
|
3.20e-54
|
GO:0009889
|
regulation of biosynthetic process
|
1.61
|
4.56e-54
|
GO:2000112
|
regulation of cellular macromolecule biosynthetic process
|
1.58
|
7.27e-54
|
GO:0031326
|
regulation of cellular biosynthetic process
|
1.58
|
1.89e-53
|
GO:0090304
|
nucleic acid metabolic process
|
1.62
|
3.56e-51
|
GO:0051252
|
regulation of RNA metabolic process
|
1.62
|
7.25e-50
|
GO:0006355
|
regulation of transcription, DNA-dependent
|
1.61
|
2.45e-49
|
GO:0016070
|
RNA metabolic process
|
1.50
|
3.18e-49
|
GO:0006139
|
nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.57
|
9.49e-48
|
GO:0010467
|
gene expression
|
1.30
|
7.42e-45
|
GO:0044238
|
primary metabolic process
|
1.30
|
2.80e-43
|
GO:0044237
|
cellular metabolic process
|
1.65
|
1.28e-40
|
GO:0032774
|
RNA biosynthetic process
|
1.65
|
3.18e-40
|
GO:0006351
|
transcription, DNA-dependent
|
1.43
|
3.84e-40
|
GO:0034641
|
cellular nitrogen compound metabolic process
|
1.42
|
1.01e-39
|
GO:0006807
|
nitrogen compound metabolic process
|
1.52
|
4.27e-37
|
GO:0009059
|
macromolecule biosynthetic process
|
1.52
|
7.99e-37
|
GO:0034645
|
cellular macromolecule biosynthetic process
|
1.24
|
2.54e-34
|
GO:0008152
|
metabolic process
|
1.84
|
1.19e-32
|
GO:0002376
|
immune system process
|
1.44
|
1.33e-31
|
GO:0048518
|
positive regulation of biological process
|
1.45
|
4.21e-29
|
GO:0048522
|
positive regulation of cellular process
|
1.37
|
4.87e-25
|
GO:0044249
|
cellular biosynthetic process
|
1.43
|
1.13e-24
|
GO:0048519
|
negative regulation of biological process
|
1.36
|
3.34e-24
|
GO:0009058
|
biosynthetic process
|
1.44
|
3.51e-23
|
GO:0048523
|
negative regulation of cellular process
|
1.12
|
5.14e-22
|
GO:0009987
|
cellular process
|
1.55
|
3.22e-20
|
GO:0010604
|
positive regulation of macromolecule metabolic process
|
1.52
|
1.35e-19
|
GO:0009893
|
positive regulation of metabolic process
|
1.54
|
1.41e-19
|
GO:0031325
|
positive regulation of cellular metabolic process
|
1.51
|
2.41e-19
|
GO:0006996
|
organelle organization
|
1.61
|
3.31e-18
|
GO:0006357
|
regulation of transcription from RNA polymerase II promoter
|
1.78
|
1.94e-17
|
GO:0002682
|
regulation of immune system process
|
1.61
|
1.97e-17
|
GO:0031328
|
positive regulation of cellular biosynthetic process
|
1.63
|
2.45e-17
|
GO:0010557
|
positive regulation of macromolecule biosynthetic process
|
1.32
|
3.66e-17
|
GO:0071840
|
cellular component organization or biogenesis
|
1.59
|
1.60e-16
|
GO:0009891
|
positive regulation of biosynthetic process
|
1.64
|
2.22e-16
|
GO:0010628
|
positive regulation of gene expression
|
1.55
|
3.09e-16
|
GO:0009892
|
negative regulation of metabolic process
|
1.93
|
3.42e-16
|
GO:0002684
|
positive regulation of immune system process
|
1.31
|
1.21e-15
|
GO:0016043
|
cellular component organization
|
2.12
|
3.10e-15
|
GO:0045321
|
leukocyte activation
|
1.56
|
3.63e-15
|
GO:0031324
|
negative regulation of cellular metabolic process
|
1.42
|
1.01e-14
|
GO:0048583
|
regulation of response to stimulus
|
1.55
|
1.43e-14
|
GO:0010605
|
negative regulation of macromolecule metabolic process
|
1.15
|
1.58e-14
|
GO:0050794
|
regulation of cellular process
|
1.57
|
3.66e-14
|
GO:0051173
|
positive regulation of nitrogen compound metabolic process
|
1.62
|
5.51e-14
|
GO:0045893
|
positive regulation of transcription, DNA-dependent
|
2.00
|
6.13e-14
|
GO:0001775
|
cell activation
|
1.53
|
6.81e-14
|
GO:0010941
|
regulation of cell death
|
1.61
|
1.19e-13
|
GO:0051254
|
positive regulation of RNA metabolic process
|
1.34
|
1.20e-13
|
GO:0044267
|
cellular protein metabolic process
|
1.34
|
1.35e-13
|
GO:0071841
|
cellular component organization or biogenesis at cellular level
|
1.53
|
2.69e-13
|
GO:0043067
|
regulation of programmed cell death
|
1.56
|
3.04e-13
|
GO:0045935
|
positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.55
|
3.79e-13
|
GO:0042127
|
regulation of cell proliferation
|
1.52
|
5.05e-13
|
GO:0042981
|
regulation of apoptosis
|
1.34
|
8.49e-13
|
GO:0071842
|
cellular component organization at cellular level
|
1.14
|
9.23e-13
|
GO:0050789
|
regulation of biological process
|
2.14
|
1.52e-12
|
GO:0046649
|
lymphocyte activation
|
1.59
|
1.92e-12
|
GO:0009890
|
negative regulation of biosynthetic process
|
1.61
|
3.70e-12
|
GO:0016265
|
death
|
1.73
|
3.89e-12
|
GO:0051276
|
chromosome organization
|
1.59
|
4.53e-12
|
GO:0031327
|
negative regulation of cellular biosynthetic process
|
1.13
|
5.62e-12
|
GO:0065007
|
biological regulation
|
1.37
|
5.63e-12
|
GO:0043412
|
macromolecule modification
|
1.63
|
6.54e-12
|
GO:0012501
|
programmed cell death
|
1.59
|
6.77e-12
|
GO:0010558
|
negative regulation of macromolecule biosynthetic process
|
1.25
|
8.84e-12
|
GO:0032502
|
developmental process
|
1.38
|
9.40e-12
|
GO:0006464
|
protein modification process
|
1.48
|
1.51e-11
|
GO:0035556
|
intracellular signal transduction
|
1.60
|
1.52e-11
|
GO:0008219
|
cell death
|
1.88
|
1.72e-11
|
GO:0016568
|
chromatin modification
|
1.63
|
2.53e-11
|
GO:0006915
|
apoptosis
|
1.30
|
2.73e-11
|
GO:0048731
|
system development
|
1.86
|
3.53e-11
|
GO:0050776
|
regulation of immune response
|
1.59
|
3.63e-11
|
GO:2000113
|
negative regulation of cellular macromolecule biosynthetic process
|
1.28
|
4.70e-11
|
GO:0019538
|
protein metabolic process
|
1.80
|
4.79e-11
|
GO:0006955
|
immune response
|
1.65
|
5.03e-11
|
GO:0045944
|
positive regulation of transcription from RNA polymerase II promoter
|
1.28
|
5.16e-11
|
GO:0048856
|
anatomical structure development
|
1.59
|
5.66e-11
|
GO:0010629
|
negative regulation of gene expression
|
1.35
|
6.67e-11
|
GO:0048513
|
organ development
|
1.58
|
1.03e-10
|
GO:0051172
|
negative regulation of nitrogen compound metabolic process
|
1.79
|
1.36e-10
|
GO:0006325
|
chromatin organization
|
1.57
|
2.33e-10
|
GO:0045934
|
negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.59
|
2.50e-10
|
GO:0070887
|
cellular response to chemical stimulus
|
1.81
|
2.70e-10
|
GO:0002520
|
immune system development
|
1.65
|
3.75e-10
|
GO:0008284
|
positive regulation of cell proliferation
|
1.25
|
7.12e-10
|
GO:0007275
|
multicellular organismal development
|
1.93
|
1.45e-09
|
GO:0050778
|
positive regulation of immune response
|
1.58
|
1.85e-09
|
GO:0045892
|
negative regulation of transcription, DNA-dependent
|
2.16
|
2.29e-09
|
GO:0002521
|
leukocyte differentiation
|
1.58
|
2.58e-09
|
GO:0051253
|
negative regulation of RNA metabolic process
|
1.85
|
2.81e-09
|
GO:0030097
|
hemopoiesis
|
1.30
|
3.86e-09
|
GO:0048869
|
cellular developmental process
|
1.78
|
7.87e-09
|
GO:0048534
|
hemopoietic or lymphoid organ development
|
1.30
|
8.89e-09
|
GO:0030154
|
cell differentiation
|
1.49
|
1.17e-08
|
GO:0007049
|
cell cycle
|
1.35
|
1.82e-08
|
GO:0051239
|
regulation of multicellular organismal process
|
1.65
|
1.84e-08
|
GO:0051726
|
regulation of cell cycle
|
1.38
|
3.66e-08
|
GO:0009966
|
regulation of signal transduction
|
2.18
|
4.96e-08
|
GO:0002757
|
immune response-activating signal transduction
|
1.41
|
5.73e-08
|
GO:0050793
|
regulation of developmental process
|
2.15
|
7.52e-08
|
GO:0002764
|
immune response-regulating signaling pathway
|
1.42
|
8.41e-08
|
GO:0032268
|
regulation of cellular protein metabolic process
|
1.44
|
1.40e-07
|
GO:2000026
|
regulation of multicellular organismal development
|
1.37
|
1.52e-07
|
GO:0033036
|
macromolecule localization
|
1.74
|
1.94e-07
|
GO:0051098
|
regulation of binding
|
2.02
|
2.03e-07
|
GO:0002253
|
activation of immune response
|
1.46
|
3.27e-07
|
GO:0048584
|
positive regulation of response to stimulus
|
1.60
|
3.33e-07
|
GO:0071310
|
cellular response to organic substance
|
1.64
|
5.78e-07
|
GO:0032583
|
regulation of gene-specific transcription
|
1.94
|
6.04e-07
|
GO:0016569
|
covalent chromatin modification
|
1.95
|
6.38e-07
|
GO:0016570
|
histone modification
|
1.45
|
7.77e-07
|
GO:0045595
|
regulation of cell differentiation
|
1.57
|
8.53e-07
|
GO:0043068
|
positive regulation of programmed cell death
|
1.56
|
8.78e-07
|
GO:0010942
|
positive regulation of cell death
|
1.58
|
9.82e-07
|
GO:0043069
|
negative regulation of programmed cell death
|
2.04
|
1.01e-06
|
GO:0002252
|
immune effector process
|
1.57
|
1.19e-06
|
GO:0060548
|
negative regulation of cell death
|
1.59
|
1.22e-06
|
GO:0043066
|
negative regulation of apoptosis
|
2.09
|
1.64e-06
|
GO:0042110
|
T cell activation
|
1.37
|
2.31e-06
|
GO:0051246
|
regulation of protein metabolic process
|
1.55
|
2.89e-06
|
GO:0043065
|
positive regulation of apoptosis
|
1.79
|
3.63e-06
|
GO:0051101
|
regulation of DNA binding
|
1.98
|
3.80e-06
|
GO:0031349
|
positive regulation of defense response
|
2.01
|
4.31e-06
|
GO:0002696
|
positive regulation of leukocyte activation
|
1.30
|
4.47e-06
|
GO:0065009
|
regulation of molecular function
|
2.05
|
4.89e-06
|
GO:0051251
|
positive regulation of lymphocyte activation
|
1.85
|
5.25e-06
|
GO:0051249
|
regulation of lymphocyte activation
|
2.11
|
5.30e-06
|
GO:0030098
|
lymphocyte differentiation
|
1.47
|
5.84e-06
|
GO:0019220
|
regulation of phosphate metabolic process
|
1.47
|
5.84e-06
|
GO:0051174
|
regulation of phosphorus metabolic process
|
1.82
|
7.15e-06
|
GO:0030036
|
actin cytoskeleton organization
|
1.28
|
8.02e-06
|
GO:0006950
|
response to stress
|
1.78
|
8.60e-06
|
GO:0002694
|
regulation of leukocyte activation
|
1.78
|
8.60e-06
|
GO:0030029
|
actin filament-based process
|
1.37
|
8.87e-06
|
GO:0006796
|
phosphate metabolic process
|
1.43
|
9.08e-06
|
GO:0031399
|
regulation of protein modification process
|
1.96
|
1.11e-05
|
GO:0050867
|
positive regulation of cell activation
|
1.36
|
1.12e-05
|
GO:0006793
|
phosphorus metabolic process
|
1.72
|
1.16e-05
|
GO:0031347
|
regulation of defense response
|
1.46
|
1.63e-05
|
GO:0042325
|
regulation of phosphorylation
|
1.64
|
1.64e-05
|
GO:0010551
|
regulation of gene-specific transcription from RNA polymerase II promoter
|
1.75
|
1.95e-05
|
GO:0050865
|
regulation of cell activation
|
1.36
|
1.96e-05
|
GO:0008104
|
protein localization
|
2.71
|
2.23e-05
|
GO:0019882
|
antigen processing and presentation
|
1.56
|
2.34e-05
|
GO:0022403
|
cell cycle phase
|
1.40
|
2.46e-05
|
GO:0045184
|
establishment of protein localization
|
1.50
|
2.54e-05
|
GO:0051094
|
positive regulation of developmental process
|
1.46
|
2.63e-05
|
GO:0046907
|
intracellular transport
|
2.33
|
2.67e-05
|
GO:0042113
|
B cell activation
|
1.48
|
3.02e-05
|
GO:0001932
|
regulation of protein phosphorylation
|
1.55
|
3.48e-05
|
GO:0000122
|
negative regulation of transcription from RNA polymerase II promoter
|
1.18
|
3.81e-05
|
GO:0051179
|
localization
|
1.76
|
4.32e-05
|
GO:0043193
|
positive regulation of gene-specific transcription
|
1.69
|
4.42e-05
|
GO:0008380
|
RNA splicing
|
1.53
|
4.53e-05
|
GO:0080134
|
regulation of response to stress
|
1.53
|
4.77e-05
|
GO:0007010
|
cytoskeleton organization
|
1.60
|
5.88e-05
|
GO:0016071
|
mRNA metabolic process
|
1.42
|
6.25e-05
|
GO:0006468
|
protein phosphorylation
|
1.85
|
6.46e-05
|
GO:0010552
|
positive regulation of gene-specific transcription from RNA polymerase II promoter
|
3.08
|
6.99e-05
|
GO:0002285
|
lymphocyte activation involved in immune response
|
1.28
|
7.85e-05
|
GO:0023051
|
regulation of signaling
|
1.62
|
8.43e-05
|
GO:0008283
|
cell proliferation
|
1.39
|
8.59e-05
|
GO:0015031
|
protein transport
|
1.66
|
8.72e-05
|
GO:0012502
|
induction of programmed cell death
|
1.57
|
9.07e-05
|
GO:0000278
|
mitotic cell cycle
|
1.48
|
1.09e-04
|
GO:0006396
|
RNA processing
|
1.68
|
1.16e-04
|
GO:0001817
|
regulation of cytokine production
|
1.45
|
1.26e-04
|
GO:0022402
|
cell cycle process
|
1.65
|
1.47e-04
|
GO:0006917
|
induction of apoptosis
|
1.54
|
1.58e-04
|
GO:0045597
|
positive regulation of cell differentiation
|
1.33
|
2.14e-04
|
GO:0032879
|
regulation of localization
|
1.74
|
2.32e-04
|
GO:0051090
|
regulation of sequence-specific DNA binding transcription factor activity
|
1.74
|
2.55e-04
|
GO:0006954
|
inflammatory response
|
1.58
|
2.80e-04
|
GO:0007243
|
intracellular protein kinase cascade
|
1.58
|
2.80e-04
|
GO:0023014
|
signal transduction via phosphorylation event
|
3.08
|
2.89e-04
|
GO:0046631
|
alpha-beta T cell activation
|
2.01
|
3.17e-04
|
GO:0045089
|
positive regulation of innate immune response
|
2.13
|
3.76e-04
|
GO:0001890
|
placenta development
|
1.90
|
4.15e-04
|
GO:0045088
|
regulation of innate immune response
|
2.47
|
4.36e-04
|
GO:0002263
|
cell activation involved in immune response
|
2.47
|
4.36e-04
|
GO:0002366
|
leukocyte activation involved in immune response
|
1.81
|
5.35e-04
|
GO:0002697
|
regulation of immune effector process
|
1.29
|
5.38e-04
|
GO:0050790
|
regulation of catalytic activity
|
1.73
|
5.46e-04
|
GO:0034097
|
response to cytokine stimulus
|
2.09
|
5.47e-04
|
GO:0002703
|
regulation of leukocyte mediated immunity
|
1.53
|
6.05e-04
|
GO:0010627
|
regulation of intracellular protein kinase cascade
|
1.36
|
6.10e-04
|
GO:0016310
|
phosphorylation
|
1.70
|
7.40e-04
|
GO:0090046
|
regulation of transcription regulator activity
|
1.51
|
7.54e-04
|
GO:0006974
|
response to DNA damage stimulus
|
1.35
|
8.11e-04
|
GO:0051649
|
establishment of localization in cell
|
1.62
|
9.35e-04
|
GO:0007264
|
small GTPase mediated signal transduction
|
2.49
|
9.46e-04
|
GO:0000082
|
G1/S transition of mitotic cell cycle
|
1.50
|
9.81e-04
|
GO:0032270
|
positive regulation of cellular protein metabolic process
|
1.99
|
9.83e-04
|
GO:0030099
|
myeloid cell differentiation
|
2.86
|
1.04e-03
|
GO:0048002
|
antigen processing and presentation of peptide antigen
|
1.46
|
1.06e-03
|
GO:0006259
|
DNA metabolic process
|
1.65
|
1.07e-03
|
GO:0010608
|
posttranscriptional regulation of gene expression
|
1.55
|
1.07e-03
|
GO:0051301
|
cell division
|
2.14
|
1.21e-03
|
GO:0002706
|
regulation of lymphocyte mediated immunity
|
1.69
|
1.41e-03
|
GO:0010564
|
regulation of cell cycle process
|
1.39
|
1.47e-03
|
GO:0033554
|
cellular response to stress
|
3.15
|
1.57e-03
|
GO:0019884
|
antigen processing and presentation of exogenous antigen
|
1.48
|
1.61e-03
|
GO:0051247
|
positive regulation of protein metabolic process
|
2.06
|
1.70e-03
|
GO:0002699
|
positive regulation of immune effector process
|
2.08
|
1.74e-03
|
GO:0045637
|
regulation of myeloid cell differentiation
|
1.85
|
1.89e-03
|
GO:0051169
|
nuclear transport
|
2.51
|
2.05e-03
|
GO:0050851
|
antigen receptor-mediated signaling pathway
|
1.30
|
2.10e-03
|
GO:0051641
|
cellular localization
|
1.26
|
2.44e-03
|
GO:0009653
|
anatomical structure morphogenesis
|
2.59
|
2.50e-03
|
GO:0030183
|
B cell differentiation
|
2.35
|
2.98e-03
|
GO:0002429
|
immune response-activating cell surface receptor signaling pathway
|
1.33
|
3.08e-03
|
GO:0051128
|
regulation of cellular component organization
|
1.22
|
3.26e-03
|
GO:0042221
|
response to chemical stimulus
|
1.62
|
3.31e-03
|
GO:0051056
|
regulation of small GTPase mediated signal transduction
|
1.32
|
3.61e-03
|
GO:0009888
|
tissue development
|
2.11
|
3.87e-03
|
GO:0002224
|
toll-like receptor signaling pathway
|
1.46
|
5.06e-03
|
GO:0051338
|
regulation of transferase activity
|
1.82
|
5.06e-03
|
GO:0006913
|
nucleocytoplasmic transport
|
2.28
|
5.10e-03
|
GO:0060326
|
cell chemotaxis
|
1.57
|
5.13e-03
|
GO:0018193
|
peptidyl-amino acid modification
|
2.03
|
5.22e-03
|
GO:0002218
|
activation of innate immune response
|
1.41
|
5.50e-03
|
GO:0044092
|
negative regulation of molecular function
|
1.56
|
6.14e-03
|
GO:0006397
|
mRNA processing
|
1.47
|
6.50e-03
|
GO:0043549
|
regulation of kinase activity
|
1.65
|
6.97e-03
|
GO:0046578
|
regulation of Ras protein signal transduction
|
1.81
|
7.19e-03
|
GO:0071345
|
cellular response to cytokine stimulus
|
1.78
|
7.22e-03
|
GO:0050863
|
regulation of T cell activation
|
1.91
|
7.39e-03
|
GO:0002237
|
response to molecule of bacterial origin
|
1.38
|
7.48e-03
|
GO:0040011
|
locomotion
|
1.28
|
7.56e-03
|
GO:0010033
|
response to organic substance
|
1.54
|
8.36e-03
|
GO:0033043
|
regulation of organelle organization
|
1.63
|
8.49e-03
|
GO:0006897
|
endocytosis
|
1.63
|
8.49e-03
|
GO:0010324
|
membrane invagination
|
1.47
|
9.03e-03
|
GO:0009611
|
response to wounding
|
1.48
|
1.04e-02
|
GO:0016477
|
cell migration
|
1.16
|
1.04e-02
|
GO:0051234
|
establishment of localization
|
2.02
|
1.12e-02
|
GO:0002221
|
pattern recognition receptor signaling pathway
|
2.65
|
1.13e-02
|
GO:0001776
|
leukocyte homeostasis
|
2.03
|
1.16e-02
|
GO:0030217
|
T cell differentiation
|
2.24
|
1.18e-02
|
GO:0002768
|
immune response-regulating cell surface receptor signaling pathway
|
2.20
|
1.22e-02
|
GO:0002756
|
MyD88-independent toll-like receptor signaling pathway
|
2.15
|
1.25e-02
|
GO:0002755
|
MyD88-dependent toll-like receptor signaling pathway
|
1.49
|
1.44e-02
|
GO:0031401
|
positive regulation of protein modification process
|
1.51
|
1.47e-02
|
GO:0070647
|
protein modification by small protein conjugation or removal
|
1.49
|
1.51e-02
|
GO:0051130
|
positive regulation of cellular component organization
|
3.03
|
1.56e-02
|
GO:0046632
|
alpha-beta T cell differentiation
|
2.68
|
1.65e-02
|
GO:0002260
|
lymphocyte homeostasis
|
1.92
|
1.75e-02
|
GO:0019221
|
cytokine-mediated signaling pathway
|
1.82
|
1.86e-02
|
GO:0010638
|
positive regulation of organelle organization
|
2.43
|
1.93e-02
|
GO:0002573
|
myeloid leukocyte differentiation
|
1.46
|
2.09e-02
|
GO:0045859
|
regulation of protein kinase activity
|
1.61
|
2.12e-02
|
GO:0071900
|
regulation of protein serine/threonine kinase activity
|
2.37
|
2.15e-02
|
GO:0030595
|
leukocyte chemotaxis
|
1.97
|
2.19e-02
|
GO:0002758
|
innate immune response-activating signal transduction
|
1.61
|
2.36e-02
|
GO:0071495
|
cellular response to endogenous stimulus
|
1.90
|
2.37e-02
|
GO:0051325
|
interphase
|
1.81
|
2.43e-02
|
GO:0070663
|
regulation of leukocyte proliferation
|
2.87
|
2.46e-02
|
GO:0002200
|
somatic diversification of immune receptors
|
1.91
|
2.53e-02
|
GO:0051329
|
interphase of mitotic cell cycle
|
2.04
|
2.57e-02
|
GO:0006473
|
protein acetylation
|
1.81
|
2.64e-02
|
GO:0050670
|
regulation of lymphocyte proliferation
|
1.63
|
2.70e-02
|
GO:0032870
|
cellular response to hormone stimulus
|
1.66
|
2.71e-02
|
GO:0007346
|
regulation of mitotic cell cycle
|
2.11
|
2.73e-02
|
GO:0016573
|
histone acetylation
|
1.49
|
2.79e-02
|
GO:0051270
|
regulation of cellular component movement
|
2.60
|
3.05e-02
|
GO:0050764
|
regulation of phagocytosis
|
1.97
|
3.19e-02
|
GO:0002443
|
leukocyte mediated immunity
|
2.37
|
3.20e-02
|
GO:0032943
|
mononuclear cell proliferation
|
1.59
|
3.39e-02
|
GO:0010562
|
positive regulation of phosphorus metabolic process
|
1.59
|
3.39e-02
|
GO:0045937
|
positive regulation of phosphate metabolic process
|
1.89
|
3.42e-02
|
GO:0018205
|
peptidyl-lysine modification
|
1.80
|
3.45e-02
|
GO:0032944
|
regulation of mononuclear cell proliferation
|
1.16
|
3.45e-02
|
GO:0006810
|
transport
|
1.38
|
3.62e-02
|
GO:0006952
|
defense response
|
1.72
|
3.80e-02
|
GO:0051099
|
positive regulation of binding
|
2.11
|
4.03e-02
|
GO:0001892
|
embryonic placenta development
|
2.13
|
4.06e-02
|
GO:0001816
|
cytokine production
|
1.93
|
4.14e-02
|
GO:0043543
|
protein acylation
|
3.41
|
4.27e-02
|
GO:0002286
|
T cell activation involved in immune response
|
3.41
|
4.27e-02
|
GO:0002474
|
antigen processing and presentation of peptide antigen via MHC class I
|
1.62
|
4.50e-02
|
GO:0001934
|
positive regulation of protein phosphorylation
|
1.57
|
4.91e-02
|
GO:0051129
|
negative regulation of cellular component organization
|